Cargando…
Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults
BACKGROUND: To study the pharmacokinetic and -dynamic behavior of landiolol in the presence of dobutamine in healthy subjects of European ancestry. METHODS: We conducted a single-center, prospective randomized study in 16 healthy subjects each receiving an infusion of dobutamine sufficient to increa...
Autores principales: | Krumpl, Günther, Ulč, Ivan, Trebs, Michaela, Kadlecová, Pavla, Hodisch, Juri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691079/ https://www.ncbi.nlm.nih.gov/pubmed/33239108 http://dx.doi.org/10.1186/s40360-020-00462-x |
Ejemplares similares
-
Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol
por: Krumpl, Günther, et al.
Publicado: (2020) -
Population pharmacokinetics and pharmacodynamics of dobutamine in neonates on the first days of life
por: Hallik, Maarja, et al.
Publicado: (2020) -
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial
por: Unger, Martin, et al.
Publicado: (2018) -
Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
por: Kunisawa, Takayuki, et al.
Publicado: (2015) -
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
por: Li, Junfeng, et al.
Publicado: (2015)